Ibudilast, a pharmacologic phosphodiesterase inhibitor, prevents human immunodeficiency virus-1 Tat-mediated activation of microglial cells.
Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorders (HAND) occur, in part, due to the inflammatory response to viral proteins, such as the HIV-1 transactivator of transcription (Tat), in the central nervous system (CNS). Given the need for novel adjunctive therapies for HAND,...
Guardado en:
Autores principales: | Michelle Kiebala, Sanjay B Maggirwar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d944338f305a4bd6b582d3fca78ac18f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nuclear factor-kappa B family member RelB inhibits human immunodeficiency virus-1 Tat-induced tumor necrosis factor-alpha production.
por: Michelle Kiebala, et al.
Publicado: (2010) -
Structural Basis for Importin-α Binding of the Human Immunodeficiency Virus Tat
por: K. M. Smith, et al.
Publicado: (2017) -
Human Immunodeficiency Virus Tat Protein Aids V Region Somatic Hypermutation in Human B Cells
por: Xiaohua Wang, et al.
Publicado: (2018) -
The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency
por: Guillaume Mousseau, et al.
Publicado: (2015) -
Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.
por: Mitsunori Ishiguro, et al.
Publicado: (2010)